https://www.avient.com/investor-center/news/avient-announces-fourth-quarter-and-full-year-2020-results-and-provides-guidance-2021
Adjusted EPS increased 11% to $1.93 pro forma, on strength in healthcare, packaging and consumer end markets
Inventory fair market value step-up expense
Pension settlement/curtailment gains and mark-to-market adjustment
https://www.avient.com/investor-center/news/polyone-announces-first-quarter-2020-results
The pandemic has negatively impacted every region and many end markets, but certain end markets such as healthcare and packaging are holding up well."
Market conditions remain challenged, as most of the world outside of
Given the uncertainty in global markets, the company does not plan to provide specific guidance for the second quarter or the balance of the year at this time.
https://www.avient.com/investor-center/news/polyone-signs-definitive-agreement-acquire-clariant-color-and-additive-masterbatch-business
for the last twelve months, includes specialty technologies and solutions for high-growth global end markets, such as consumer, packaging, and healthcare.
Over the years, we have invested heavily in commercial resources and innovation, emphasizing higher-margin specialty business in less-cyclical end markets.
color and additive masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisition and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/company/sustainability/sustainability-report/reporting/sasb
Revenue by Geography and End Market:
Geography: 40% US/Canada, 37% EMEA, 18% Asia, 5% Latin America End Market: 20% Consumer, 24% Packaging, 8% Healthcare, 15% Industrial, 9% Transportation, 10% Building and Construction, 4% Telecommunications, 4% Energy, 4% Defense
Part of this metric was omitted due to lack of availability (production, in units, per reportable segment).
Who We Are—Revenue by Geography and End Market
https://www.avient.com/investor-center/news/polyone-signs-agreement-divest-performance-products-and-solutions-business-segment
and Automotive end markets.
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the time required to consummate the proposed divestiture; the satisfaction or waiver of conditions in the sale agreement; any material adverse changes in the business supporting the PP&S assets being sold; the ability to obtain required regulatory or other third-party approvals and consents and otherwise consummate the proposed divestiture; our ability to identify and evaluate acquisition targets and consummate and integrate acquisitions; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, cost reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
https://www.avient.com/company/sustainability/sustainability-report/products/product-stewardship-global-chemical-management-product-excellence
In addition, for this reporting period there have been zero incidences of product recalls due to non-compliance in the markets we serve.
For our sensitive applications we have implemented Good Manufacturing Processes (GMP) and ISO 13485. 100% of our facilities producing for the healthcare market are GMP or ISO audited within a 3–year period.
https://www.avient.com/products/polymer-additives/healthcare-additives/mevopur-healthcare-functional-additives
Marketing + Technical Info
Explore how Avient Healthcare Polymer Colorant and Additive Solutions can support the growing healthcare market trends by helping our customers to manage product performance and risk.
https://www.avient.com/products/thermoplastic-elastomers/versaflex-hc-thermoplastic-elastomers
Marketing + Technical Info
Versaflex™ HC Thermoplastic Elastomers provided a medical-grade TPE to help the customer meet necessary regulatory specifications and gain market share
https://www.avient.com/idea/electric-car-quickens-pulse-color
After grabbing more than 8% of the market within six months of the release of its flagship vehicle, the engineers at a game-changing electric car manufacturer went back to work fine-tuning the details.
https://www.avient.com/products/polymer-additives/clarifier-additives/cesa-nucleant-additives
Marketing + Technical Info